Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Arjo AB (publ) stock logo
ARRJF
Arjo AB (publ)
$3.07
$3.07
$3.07
$4.11
N/AN/A4,700 shsN/A
McKesson Europe AG stock logo
CAKFY
McKesson Europe
$4.10
$4.10
$4.04
$4.10
N/AN/A10,050 shsN/A
Peapack-Gladstone Financial Corporation stock logo
PGC
Peapack-Gladstone Financial
$30.37
+2.3%
$28.01
$20.98
$37.88
$538.82M0.8691,663 shs37,357 shs
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
$11.77
+0.4%
$11.81
$10.13
$15.26
N/AN/A16,138 shs8,917 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Arjo AB (publ) stock logo
ARRJF
Arjo AB (publ)
0.00%0.00%0.00%0.00%-33.12%
McKesson Europe AG stock logo
CAKFY
McKesson Europe
0.00%0.00%0.00%0.00%0.00%
Peapack-Gladstone Financial Corporation stock logo
PGC
Peapack-Gladstone Financial
0.00%+7.50%+10.76%+19.61%+37.55%
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
0.00%-0.43%-0.68%+4.07%-11.61%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Arjo AB (publ) stock logo
ARRJF
Arjo AB (publ)
N/AN/AN/AN/AN/AN/AN/AN/A
McKesson Europe AG stock logo
CAKFY
McKesson Europe
N/AN/AN/AN/AN/AN/AN/AN/A
Peapack-Gladstone Financial Corporation stock logo
PGC
Peapack-Gladstone Financial
3.6886 of 5 stars
2.72.01.70.01.51.73.8
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Arjo AB (publ) stock logo
ARRJF
Arjo AB (publ)
0.00
N/AN/AN/A
McKesson Europe AG stock logo
CAKFY
McKesson Europe
0.00
N/AN/AN/A
Peapack-Gladstone Financial Corporation stock logo
PGC
Peapack-Gladstone Financial
3.33
Buy$37.3322.93% Upside
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest SHTDY, ARRJF, EBO, CAKFY, and PGC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/24/2025
Peapack-Gladstone Financial Corporation stock logo
PGC
Peapack-Gladstone Financial
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$40.00 ➝ $38.00
4/11/2025
Peapack-Gladstone Financial Corporation stock logo
PGC
Peapack-Gladstone Financial
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageStrong-Buy$39.00
(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Arjo AB (publ) stock logo
ARRJF
Arjo AB (publ)
N/AN/AN/AN/AN/AN/A
McKesson Europe AG stock logo
CAKFY
McKesson Europe
N/AN/AN/AN/AN/AN/A
Peapack-Gladstone Financial Corporation stock logo
PGC
Peapack-Gladstone Financial
$406.92M1.32$2.50 per share12.16$34.45 per share0.88
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Arjo AB (publ) stock logo
ARRJF
Arjo AB (publ)
N/AN/A0.00N/AN/AN/AN/A7/11/2025 (Estimated)
McKesson Europe AG stock logo
CAKFY
McKesson Europe
N/A$0.0947.67N/AN/AN/AN/AN/A
Peapack-Gladstone Financial Corporation stock logo
PGC
Peapack-Gladstone Financial
$32.99M$1.8016.877.52N/A7.71%5.27%0.47%7/22/2025 (Estimated)
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/A$4.992.36N/AN/AN/AN/A8/21/2025 (Estimated)

Latest SHTDY, ARRJF, EBO, CAKFY, and PGC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/22/2025Q2 2025
Peapack-Gladstone Financial Corporation stock logo
PGC
Peapack-Gladstone Financial
$0.61N/AN/AN/A$69.77 millionN/A
4/22/2025Q1 2025
Peapack-Gladstone Financial Corporation stock logo
PGC
Peapack-Gladstone Financial
$0.51$0.43-$0.08$0.43$64.07 million$64.36 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Arjo AB (publ) stock logo
ARRJF
Arjo AB (publ)
N/AN/AN/AN/AN/A
McKesson Europe AG stock logo
CAKFY
McKesson Europe
$0.040.91%N/A43.18%N/A
Peapack-Gladstone Financial Corporation stock logo
PGC
Peapack-Gladstone Financial
$0.200.66%N/A11.11%N/A
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/AN/AN/AN/AN/A

Latest SHTDY, ARRJF, EBO, CAKFY, and PGC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/14/2025
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
$0.35422.91%6/17/20256/18/20258/27/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Arjo AB (publ) stock logo
ARRJF
Arjo AB (publ)
N/AN/AN/A
McKesson Europe AG stock logo
CAKFY
McKesson Europe
N/AN/AN/A
Peapack-Gladstone Financial Corporation stock logo
PGC
Peapack-Gladstone Financial
0.16
0.95
0.94
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Arjo AB (publ) stock logo
ARRJF
Arjo AB (publ)
N/A
McKesson Europe AG stock logo
CAKFY
McKesson Europe
0.01%
Peapack-Gladstone Financial Corporation stock logo
PGC
Peapack-Gladstone Financial
72.75%
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Arjo AB (publ) stock logo
ARRJF
Arjo AB (publ)
6,500N/AN/ANot Optionable
McKesson Europe AG stock logo
CAKFY
McKesson Europe
26,329N/AN/ANot Optionable
Peapack-Gladstone Financial Corporation stock logo
PGC
Peapack-Gladstone Financial
50017.74 million16.38 millionOptionable
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
115,959N/AN/ANot Optionable

Recent News About These Companies

Sinopharm Group Reports Q1 2025 Financial Results
3 Compelling Dividend Stocks Offering Yields Up To 5.1%
Sinopharm Group Proposes New Director Appointments
3 Dividend Stocks Yielding Up To 4.5%
Revolutionary drug for schizophrenia wins US approval
Dr. Shan Siddiqi: PTSD treatment breakthrough?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Arjo AB (publ) stock logo

Arjo AB (publ) OTCMKTS:ARRJF

$3.07 0.00 (0.00%)
As of 07/3/2025

Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, prone positioning early mobility, and rehabilitation services, as well as maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. Arjo AB (publ) was founded in 1957 and is headquartered in Malmö, Sweden.

McKesson Europe stock logo

McKesson Europe OTCMKTS:CAKFY

$4.10 0.00 (0.00%)
As of 07/11/2023

McKesson Europe AG provides logistics and other services to the pharmaceutical and healthcare sectors worldwide. The company operates through two divisions, Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution division engages in the wholesale of pharmaceutical and other health care products. This division serves its customers through 90 wholesale branches that supply pharmaceutical products to approximately 40,000 pharmacies and hospitals, as well as operates 70 distribution centers in Europe. The Retail Pharmacy division operates approximately 2,000 owned pharmacies and approximately 8,000 members in its brand partnership program. This division also provides outpatient drug, e-commerce, and home care services primarily in Belgium, Ireland, Italy, and the United Kingdom under the Lloyds Pharmacy brand. In addition, this division provides traditional prescription drugs, over-the-counter products, and medical services. It also provides other services for pharmacists, such as the organization and management of pharmacy cooperation programs in the Great Britain, France, Portugal, and Belgium. The company was formerly known as Celesio AG and changed its name to McKesson Europe AG in September 2017. The company was founded in 1835 and is headquartered in Stuttgart, Germany. McKesson Europe AG is a subsidiary of McKesson Corporation.

Peapack-Gladstone Financial stock logo

Peapack-Gladstone Financial NASDAQ:PGC

$30.37 +0.69 (+2.32%)
As of 07/3/2025 01:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Peapack-Gladstone Financial Corporation operates as the bank holding company for Peapack-Gladstone Bank that provides private banking and wealth management services in the United States. The company operates in two segments, Banking and Peapack Private. It offers checking and savings accounts, money market and interest-bearing checking accounts, certificates of deposit, and individual retirement accounts. The company also provides working capital lines of credit, term loans for fixed asset acquisitions, commercial mortgages, multi-family mortgages, and other forms of asset-based financing services; and residential mortgages, home equity lines of credit, and other second mortgage loans. In addition, it offers corporate and industrial (C&I) and equipment finance, commercial real estate, multifamily, residential, and consumer lending activities; treasury management services; C&I advisory services; escrow management; deposit generation; investment management services; personal trust services, including services as executor, trustee, administrator, custodian, and guardian; and other financial planning, tax preparation, and advisory services. Further, the company provides telephone and Internet banking, merchant credit card, and customer support sales services. Its private banking clients include businesses, non-profits, and consumers; wealth management clients comprise individuals, families, foundations, endowments, trusts, and estates; and commercial loan clients include business owners, professionals, retailers, contractors, and real estate investors. The company operates its private banking locations in Bedminster, Morristown, Princeton, and Teaneck, New Jersey; and branches in Somerset, Morris, Hunterdon, and Union counties, as well as operates automated teller machines. Peapack-Gladstone Financial Corporation was founded in 1921 and is headquartered in Bedminster, New Jersey.

Sinopharm Group stock logo

Sinopharm Group OTCMKTS:SHTDY

$11.77 +0.04 (+0.35%)
As of 07/3/2025 12:51 PM Eastern

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.